ЕРИТРОПОЕТИН ЯК НЕЗАЛЕЖНИЙ ПРОГНОСТИЧНИЙ ФАКТОР У ХВОРИХ НА МІЄЛОДИСПЛАСТИЧНІ СИНДРОМИ
Aim: To assess the level of erythropoietin (EPO) in blood sera of patients with different subtypes of myelodysplastic syndromes (MDS) from different risk subgroups and to determine its prognostic role. Materials and Methods: EPO was measured by enzyme-linked immunosorbent assay in peripheral blood o...
Gespeichert in:
| Datum: | 2023 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
PH Akademperiodyka
2023
|
| Schlagworte: | |
| Online Zugang: | https://exp-oncology.com.ua/index.php/Exp/article/view/2021-1-11 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Experimental Oncology |